The increasing importance of Real World Evidence (RWE) and the need for a multi-stakeholder approach

What is Needed to Reinforce Biopharmaceutical Innovation in Europe?

The European Health Data Space (EHDS): How will it impact health technology companies operating in or about to enter the EU?

GUEST: What’s on the horizon for life sciences and health care?

From the EUCOPE Blog archives

Five Priorities for a Successful EU HTA Procedure

April 27, 2022


HERA: closer coordination in the EU against COVID-19

February 26, 2021


Is it Time for a new Health Paradigm in the EU?

November 20, 2020


Harnessing Europe’s untapped potential: small and medium pharma

June 2, 2020


ECRD 2020: OMPs Development in a post-COVID-19 World

May 15, 2020


To the archives